JP5106097B2 - 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出 - Google Patents

未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出 Download PDF

Info

Publication number
JP5106097B2
JP5106097B2 JP2007504379A JP2007504379A JP5106097B2 JP 5106097 B2 JP5106097 B2 JP 5106097B2 JP 2007504379 A JP2007504379 A JP 2007504379A JP 2007504379 A JP2007504379 A JP 2007504379A JP 5106097 B2 JP5106097 B2 JP 5106097B2
Authority
JP
Japan
Prior art keywords
heparin
glycoserine
permanganate
added
stirring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2007504379A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530722A (ja
JP2007530722A5 (enExample
Inventor
ムリエ，ピエール
ビスコブ，クリスチアン
Original Assignee
アバンテイス・フアルマ・エス・アー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アバンテイス・フアルマ・エス・アー filed Critical アバンテイス・フアルマ・エス・アー
Publication of JP2007530722A publication Critical patent/JP2007530722A/ja
Publication of JP2007530722A5 publication Critical patent/JP2007530722A5/ja
Application granted granted Critical
Publication of JP5106097B2 publication Critical patent/JP5106097B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C08B37/0078—Degradation products
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
JP2007504379A 2004-03-24 2005-03-22 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出 Expired - Fee Related JP5106097B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04290791A EP1582531A1 (en) 2004-03-24 2004-03-24 Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products
EP04290791.5 2004-03-24
PCT/EP2005/003719 WO2005090411A1 (en) 2004-03-24 2005-03-22 Process for oxidizing unfractionated heparins and detecting presence or absence of glycoserine in heparin and heparin products

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2011285228A Division JP2012111758A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
JP2011285227A Division JP2012103263A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出

Publications (3)

Publication Number Publication Date
JP2007530722A JP2007530722A (ja) 2007-11-01
JP2007530722A5 JP2007530722A5 (enExample) 2012-10-18
JP5106097B2 true JP5106097B2 (ja) 2012-12-26

Family

ID=34878328

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2007504379A Expired - Fee Related JP5106097B2 (ja) 2004-03-24 2005-03-22 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
JP2011285228A Pending JP2012111758A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
JP2011285227A Pending JP2012103263A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2011285228A Pending JP2012111758A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
JP2011285227A Pending JP2012103263A (ja) 2004-03-24 2011-12-27 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出

Country Status (11)

Country Link
US (2) US20050215519A1 (enExample)
EP (4) EP1582531A1 (enExample)
JP (3) JP5106097B2 (enExample)
CA (1) CA2558559A1 (enExample)
CY (1) CY1113993T1 (enExample)
DK (1) DK2314632T3 (enExample)
ES (1) ES2403082T3 (enExample)
PL (1) PL2314632T3 (enExample)
PT (1) PT2314632E (enExample)
SI (1) SI2314632T1 (enExample)
WO (1) WO2005090411A1 (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1319183E (pt) 2000-09-12 2009-06-29 Massachusetts Inst Technology Métodos e produtos relacionados a heparina de baixo peso molecular
JP4828795B2 (ja) 2002-03-11 2011-11-30 モメンタ ファーマシューティカルズ インコーポレイテッド 硫酸化多糖類の分析
JP4965999B2 (ja) * 2005-12-27 2012-07-04 セント ルイス ユニバーシティ ムコ多糖症の診断方法
US8101733B1 (en) 2006-06-27 2012-01-24 Momenta Pharmaceuticals, Inc. Methods of evaluating mixtures of polysaccharides
US7790466B1 (en) 2007-01-26 2010-09-07 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by chain profiles or chain mapping
US7968082B1 (en) 2007-01-26 2011-06-28 Momenta Pharmaceuticals, Inc. Evaluating mixtures of low molecular weight heparins by NMR
US9139876B1 (en) 2007-05-03 2015-09-22 Momenta Pharmacueticals, Inc. Method of analyzing a preparation of a low molecular weight heparin
EP2256137A1 (en) * 2009-05-05 2010-12-01 Sanofi-Aventis Novel sulfated octasaccharide and its use as antithrombotic agent
EP2256136A1 (en) * 2009-05-05 2010-12-01 Sanofi-Aventis Novel acylated decasaccharides and their use as antithrombotic agents
CN102791742B (zh) * 2010-01-19 2014-12-24 动量制药公司 评价肝素制剂
WO2012115952A1 (en) 2011-02-21 2012-08-30 Momenta Pharmaceuticals, Inc. Evaluating heparin preparations
CN102153676B (zh) * 2011-03-04 2012-07-04 南京健友生化制药股份有限公司 采用真空干燥去除肝素钠中有机残留的方法
WO2013095215A1 (en) 2011-12-19 2013-06-27 Dilaforette Ab Low anticoagulant heparins
JP6543467B2 (ja) 2011-12-19 2019-07-10 ディラホア アクチエボラゲット 二糖繰り返し単位を含んでいる非抗凝固グリコサミノグリカンおよびそれらの医療用途
US20150011501A1 (en) * 2012-02-17 2015-01-08 Kimflexor, S.L. Partially depolymerized glycosaminoglycan silver and gold salts
JP5911757B2 (ja) * 2012-06-08 2016-04-27 ソニー株式会社 基板処理方法、基板処理装置、および記録媒体
CN103030715B (zh) * 2012-12-07 2015-05-06 青岛九龙生物医药有限公司 一种分离纯化肝素钠的方法
CN103044577B (zh) * 2012-12-07 2015-05-06 青岛九龙生物医药有限公司 一种降低肝素钠产品中硫酸皮肤素含量的方法
CN103044578B (zh) * 2012-12-07 2015-05-06 青岛九龙生物医药有限公司 一种高效精制粗品肝素钠的方法
CN103145875B (zh) * 2012-12-07 2015-11-25 青岛九龙生物医药有限公司 一种降低肝素钠中有机溶剂残留的工艺方法
CN103145878B (zh) * 2012-12-08 2016-04-13 青岛九龙生物医药有限公司 一种超低分肝素钠工艺研究
CN103214597B (zh) * 2013-05-14 2015-11-11 枣庄赛诺康生化股份有限公司 依诺肝素钠中间体脱色方法
CN103421128B (zh) * 2013-07-31 2015-08-12 山东辰中生物制药有限公司 一种高品质低分子帕那肝素的制备方法
CN103665193A (zh) * 2013-11-23 2014-03-26 青岛九龙生物医药有限公司 一种提高肝素钠效价的方法
CN103864958A (zh) * 2013-11-24 2014-06-18 青岛九龙生物医药有限公司 一种制备高纯度肝素钠的方法
CN104764847B (zh) * 2015-04-21 2016-08-17 福州大学 含n-乙酰化结构肝素寡糖的制备方法
CN106442799B (zh) * 2016-11-04 2019-03-05 深圳市天道医药有限公司 一种低分子肝素分子量及分子量分布检测方法
JP2021513593A (ja) 2018-02-14 2021-05-27 バイオロジカル イー リミテッド ダルテパリンナトリウムを調製する改善された方法
CN110885386A (zh) * 2019-12-23 2020-03-17 天津生物化学制药有限公司 一种利用那屈肝素钙废料提取超低分子量肝素钠的方法
CN114689722A (zh) * 2020-12-31 2022-07-01 深圳市海普瑞药业集团股份有限公司 一种用于检测样品中糖胺聚糖羧酸化衍生物含量的方法及其应用
CN115286725B (zh) * 2022-08-31 2023-06-02 山东万邦赛诺康生化制药股份有限公司 一种高纯度低分子量肝素的制备方法
CN116444697A (zh) * 2023-03-20 2023-07-18 河北常山凯库得生物技术有限公司 一种羊源肝素钠的精制方法

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US766992A (en) * 1903-10-12 1904-08-09 Richard F May Car-ventilator.
GB766992A (en) 1954-03-19 1957-01-30 Boots Pure Drug Co Ltd Improvements in or relating to the production of heparin
US3135660A (en) * 1956-11-09 1964-06-02 Riker Laboratories Inc Method for purifying sulfated carbohydrates with oxidizing agents
US3174904A (en) * 1963-03-25 1965-03-23 Rexall Drug Chemical Method of purifying sulfated carbohydrates
US3766167A (en) * 1971-03-26 1973-10-16 Research Corp Orally active anticoagulant
IT1083903B (it) * 1977-08-09 1985-05-25 Lobo Srl Oligo-eteropolisaccaridi con attivita' eparinosimili,procedimento per il loro ottenimento e relative composizioni terapeutiche
FR2478646A2 (fr) 1980-03-20 1981-09-25 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
FR2440376A1 (fr) 1978-11-06 1980-05-30 Choay Sa Composition mucopolysaccharidique ayant une activite regulatrice de la coagulation, medicament la contenant et procede pour l'obtenir
US4692435A (en) * 1978-11-06 1987-09-08 Choay, S.A. Mucopolysaccharide composition having a regulatory action on coagulation, medicament containing same and process of preparation
CA1136620A (en) * 1979-01-08 1982-11-30 Ulf P.F. Lindahl Heparin fragments having selective anticoagulation activity
GB2051103A (en) 1979-04-11 1981-01-14 Choay Sa Heparin fractions
IL61201A (en) * 1979-10-05 1984-09-30 Choay Sa Oligosaccharides having no more than 8 saccharide moieties,their obtention from heparin and pharmaceutical compositions containing them
US4826827A (en) * 1979-10-05 1989-05-02 Choay S.A. Short chained oligosaccharides having biological properties, a process for making the same and the use thereof as drugs
FR2482611B1 (fr) 1980-05-14 1986-03-07 Pharmindustrie Nouveaux polysaccharides sulfates, procedes pour leur preparation et leur utilisation comme medicaments
US4351938A (en) 1980-05-19 1982-09-28 Riker Laboratories, Inc. Anticoagulant substance
CA1171375A (en) * 1980-09-15 1984-07-24 Ulf P.F. Lindahl Oligosaccharides having selective anticoagulation activity
FR2503714B1 (fr) 1981-04-10 1986-11-21 Choay Sa Procede d'obtention de mucopolysaccharides biologiquement actifs, de purete elevee, par depolymerisation de l'heparine
FR2504928A1 (fr) 1981-04-29 1982-11-05 Choay Sa Oligosaccharides a chaines courtes possedant des proprietes biologiques, leur preparation et leurs applications en tant que medicaments
US4396762A (en) * 1981-08-24 1983-08-02 Massachusetts Institute Of Technology Heparinase derived anticoagulants
US4533549A (en) * 1983-01-04 1985-08-06 Lasker Sigmund E Antithrombotic agent
IT1195497B (it) * 1983-03-08 1988-10-19 Opocrin Spa Procedimento per la preparazione di frazioni oligosaccaridiche dotate di proprieta' farmacologiche per degradazione chimica di eparina
DE3519011A1 (de) * 1985-05-25 1986-11-27 Behringwerke Ag, 3550 Marburg Verfahren zur herstellung eines materials zur affinitaetschromatographie
DK196886D0 (da) * 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider
DK196986D0 (da) 1986-04-30 1986-04-30 Novo Industri As Fremstilling af polysaccharider
US4833155A (en) 1986-11-25 1989-05-23 Syntex (U.S.A.) Inc. 3-(ω-(3,5,-di-t-butyl-4-hydroxyphenyl)-alkanoyl)pyrroles, and anti-inflammatory uses thereof
FR2614026B1 (fr) 1987-04-16 1992-04-17 Sanofi Sa Heparines de bas poids moleculaire, a structure reguliere, leur preparation et leurs applications biologiques
IT1234508B (it) 1988-06-10 1992-05-19 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
US4981955A (en) * 1988-06-28 1991-01-01 Lopez Lorenzo L Depolymerization method of heparin
NL8900119A (nl) * 1989-01-19 1990-08-16 Akzo Nv Werkwijze voor het afsplitsen van (delta)4-onverzadigd uronzuur in glycosaminoglycaan fragmenten.
IT1234826B (it) 1989-01-30 1992-05-29 Alfa Wassermann Spa Derivati eparinici e procedimento per la loro preparazione
FR2663639B1 (fr) * 1990-06-26 1994-03-18 Rhone Poulenc Sante Melanges de polysaccharides de bas poids moleculaires procede de preparation et utilisation.
FR2704861B1 (fr) 1993-05-07 1995-07-28 Sanofi Elf Fractions d'héparine purifiées, procédé d'obtention et compositions pharmaceutiques les contenant.
AU7753898A (en) * 1997-06-06 1998-12-21 Hamilton Civic Hospitals Research Development, Inc. Modified low molecular weight heparin that inhibits clot associated coagulation factors
FR2800074B1 (fr) 1999-10-22 2001-12-21 Aventis Pharma Sa Nouveaux oligosaccharides, leur preparation et les compositions pharmaceutiques les contenant
US6969705B2 (en) * 2000-07-21 2005-11-29 Aventis Pharma S.A. Compositions of polysaccharides derived from heparin, their preparation and pharmaceutical compositions containing them
EP1558755B1 (fr) * 2002-09-23 2012-10-24 Aventis Pharma S.A. Methode de determination de groupements specifiques constituant les heparines

Also Published As

Publication number Publication date
ES2403082T3 (es) 2013-05-14
US20050215519A1 (en) 2005-09-29
JP2012103263A (ja) 2012-05-31
JP2012111758A (ja) 2012-06-14
EP2314631A3 (en) 2011-06-22
PT2314632E (pt) 2013-04-17
SI2314632T1 (sl) 2013-04-30
EP2314632B1 (en) 2013-01-23
EP1582531A1 (en) 2005-10-05
EP2314631A2 (en) 2011-04-27
EP2314632A3 (en) 2011-12-14
CA2558559A1 (en) 2005-09-29
JP2007530722A (ja) 2007-11-01
PL2314632T3 (pl) 2013-06-28
WO2005090411A1 (en) 2005-09-29
EP1742972A1 (en) 2007-01-17
CY1113993T1 (el) 2016-07-27
US20080318328A1 (en) 2008-12-25
DK2314632T3 (da) 2013-04-29
EP2314632A2 (en) 2011-04-27

Similar Documents

Publication Publication Date Title
JP5106097B2 (ja) 未分画ヘパリンの酸化方法及びヘパリン及びヘパリン製品中のグリコセリンの有無の検出
DK173385B1 (da) Analogifremgangsmåde til fremstilling af oligosaccharidfraktioner eller oligosaccharider med specifik anti-Xa-aktivitet
US5039529A (en) Novel heparin derivatives
DK173818B1 (da) Heparinderivat
JP2007530932A (ja) Ｈｐｌｃを使用して、特異的に構成するヘパリン又は低分子量ヘパリンを定量的に測定するための方法
Fu et al. Structure and activity of a new low-molecular-weight heparin produced by enzymatic ultrafiltration
CN107759712B (zh) 羊来源的低分子肝素及其制备方法与应用
JP4373917B2 (ja) ヘパリンを形成している特異基の測定方法
USRE35770E (en) Oligosaccharides having anti-Xa activity and pharmaceutical compositions containing them
Yu et al. Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase
US8101733B1 (en) Methods of evaluating mixtures of polysaccharides
JPH0616687A (ja) ヘパリン不飽和４糖およびその製造法
JPH1135603A5 (enExample)
CN116448902A (zh) 一种未分级肝素或低分子肝素物种来源的鉴别方法
HK1102096A (en) Method for quantitatively determining specific constituting heparins or low molecular weight heparins using hplc
HK1081601B (en) Method of determining specific groups forming heparins
HK1108453A (en) Method of determining specific groups forming heparins
HK1102054A (en) Oligosaccharides, preparation method and use thereof, and pharmaceutical compositions containing same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080305

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110628

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20110922

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20110930

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20111227

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120529

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20120828

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120925

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20121002

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20151012

Year of fee payment: 3

LAPS Cancellation because of no payment of annual fees